KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Current Taxes (2017 - 2025)

Sarepta Therapeutics has reported Current Taxes over the past 7 years, most recently at $9.1 million for Q3 2025.

  • Quarterly results put Current Taxes at $9.1 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $9.1 million (changed N/A YoY), and the annual figure for FY2024 was $17.4 million, up 26.33%.
  • Current Taxes for Q3 2025 was $9.1 million at Sarepta Therapeutics, down from $18.7 million in the prior quarter.
  • Over the last five years, Current Taxes for SRPT hit a ceiling of $79.9 million in Q1 2025 and a floor of $216000.0 in Q4 2021.
  • Median Current Taxes over the past 5 years was $16.7 million (2023), compared with a mean of $19.6 million.
  • Biggest five-year swings in Current Taxes: surged 5696.76% in 2022 and later increased 9.94% in 2023.
  • Sarepta Therapeutics' Current Taxes stood at $216000.0 in 2021, then surged by 5696.76% to $12.5 million in 2022, then increased by 9.94% to $13.8 million in 2023, then rose by 26.33% to $17.4 million in 2024, then tumbled by 47.73% to $9.1 million in 2025.
  • The last three reported values for Current Taxes were $9.1 million (Q3 2025), $18.7 million (Q2 2025), and $79.9 million (Q1 2025) per Business Quant data.